Patents-Review.com
🔗 Permalink
Assignee profile:

Millenium Pharmaceuticals, Inc.

City:

Cambridge, Massachusetts

Country:

United States

Published Applications:

19

Last publication date:

2020-01-02

Patent Grants:

16

Last grant date:

2020-03-31

Top Inventors for applications by Millenium Pharmaceuticals, Inc.

These are the the leading inventors for applications assigned to Millenium Pharmaceuticals, Inc.:

Recent patent applications by Millenium Pharmaceuticals, Inc.

Millenium Pharmaceuticals, Inc. based in Cambridge, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2020-01-02 ✅ Patent 10,604,538 granted on 2020-03-31
US20200002361A1
Chemistry; metallurgy

Boronate ester compounds and pharmaceutical compositions thereof

 #2 | 2019-01-31 ✅ Patent 10,836,766 granted on 2020-11-17
US20190031662A1
Chemistry; metallurgy

Aurora kinase inhibitors for inhibiting mitotic progression

 #3 | 2016-11-17 ✅ Patent 10,030,016 granted on 2018-07-24
US20160331756A1
Human necessities

Heterocyclic compounds useful as PDK1 inhibitors

 #4 | 2015-06-18 ✅ Patent 9,765,076 granted on 2017-09-19
US20150166545A1
Chemistry; metallurgy

Aurora kinase inhibitors for inhibiting mitotic progression

 #5 | 2014-06-05 ✅ Patent 8,815,887 granted on 2014-08-26
US20140155437A1
Chemistry; metallurgy

Prophylactic or therapeutic method for Sjogren's syndrome

 #6 | 2014-01-09
US20140010799A1
Chemistry; metallurgy

HUMAN DIACYLGLYCEROL ACYLTRANSFERASE 2 (DGAT2) FAMILY MEMBERS AND USES THEREFOR

 #7 | 2012-10-11
US20120258927A1
Human necessities

INHIBITORS OF E1 ACTIVATING ENZYMES

 #8 | 2010-08-10 ✅ Patent 7,771,953 granted on 2010-08-10
US10736112
-

Methods of diagnosing and treating cancer

 #9 | 2008-11-18 ✅ Patent 7,452,967 granted on 2008-11-18
US10325917
-

Molecules of the card-related protein family and uses thereof

 #10 | 2008-10-28 ✅ Patent 7,442,830 granted on 2008-10-28
US11890412
-

Proteasome inhibitors

 #11 | 2008-05-08 ✅ Patent 7,943,640 granted on 2011-05-17
US20080108656A1
Chemistry; metallurgy

Compositions and methods for inhibiting TGF-β

 #12 | 2007-05-17 ✅ Patent 7,598,276 granted on 2009-10-06
US20070112039A1
Human necessities

Pharmaceutical salts and polymorphs of a factor Xa inhibitor

 #13 | 2007-02-15 ✅ Patent 7,598,375 granted on 2009-10-06
US20070037972A1
Chemistry; metallurgy

Method of acylating maytansinol with chiral amino acids

 #14 | 2006-10-24 ✅ Patent 7,125,663 granted on 2006-10-24
US10171311
-

Genes, compositions, kits and methods for identification, assessment, prevention, and therapy of cervical cancer

 #15 | 2006-08-17 ✅ Patent 7,527,962 granted on 2009-05-05
US20060183210A1
Chemistry; metallurgy

Human diacylglycerol acyltransferase 2 (DGAT2) family members and uses therefor

 #16 | 2005-12-20 ✅ Patent 6,977,240 granted on 2005-12-20
US9950149
-

Methods of using the OB receptor antibodies to treat bodyweight disorders

 #17 | 2005-09-01
US20050191614A1
Chemistry; metallurgy

High-throughput formation, identification and analysis of diverse solid forms

 #18 | 2005-03-01 ✅ Patent 6,861,504 granted on 2005-03-01
US10002585
-

Compounds and methods for the modulation of CD154

 #19 | 2005-02-17 ✅ Patent 7,361,511 granted on 2008-04-22
US20050037010A1
Chemistry; metallurgy

Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer
AssigneeID:

51237 ⎘